CN Patent

CN115397392A — 眼用药物组合物

Assigned to Vanda Pharmaceuticals Inc · Expires 2022-11-25 · 3y expired

What this patent protects

本发明提供了式(I)的化合物的眼用药物组合物：

USPTO Abstract

本发明提供了式(I)的化合物的眼用药物组合物：

Drugs covered by this patent

Patent Metadata

Patent number
CN115397392A
Jurisdiction
CN
Classification
—
Expires
2022-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Vanda Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.